| Similar Articles |
|---|
 |
Chemistry World
July 13, 2007
Hepeng Jia |
Chinese Legislation to Increase Drug Safety A long-awaited amendment to China's drug registration system is expected to discipline the country's medical sector and boost the pharmaceutical industry.   |
Chemistry World
May 18, 2007
Hepeng Jia |
China's Battle with Fake Drugs While China's pharmaceutical industry is experiencing rapid growth, a boom in counterfeit drugs is costing human lives and eroding the public's confidence in medical products. |
Chemistry World
August 10, 2007
Hepeng Jia |
China Invests More Than $1 Billion in Drug Safety In a bid to improve its food and drug safety, China has announced it will invest 8.8 billion yuan (US$1.16 billion) in the coming four years to improve its food and drug inspection and monitoring infrastructure. |
Chemistry World
May 8, 2008
Hepeng Jia |
China to fast track pioneering drugs China is to speed up the approval of groundbreaking new drugs in an effort to encourage innovation in its pharmaceutical sector, a State Food and Drug Administration (SFDA) official has revealed. |
Chemistry World
August 6, 2014
Hepeng Jia |
GSK's China troubles continue The company faces official prosecution over accusations of bribery and corruption, litigation from fired employees and an upcoming trial of private investigators employed to look into a blackmail attempt. |
Chemistry World
July 29, 2013
Hepeng Jia |
China corruption investigation broadens Investigations of corrupt practices at GlaxoSmithKline in China are continuing. But analysts claim that the scandal is an attempt to remodel the Chinese drugs market, rather than a deliberate attack on international companies. |
Chemistry World
July 9, 2014
Hepeng Jia |
China struggles to speed up drug reviews The China Food and Drug Administration is attempting to outsource some reviewing processes and introducing fast-track priority reviews for selected generic drugs. |
The Motley Fool
November 30, 2010
Brian Orelli |
A Witty Response to Pharma's R&D Dilemma According to GlaxoSmithKline CEO Andrew Witty, the pharmaceutical industry is a mess. That's the basic gist of his opinion piece in The Economist. |
Chemistry World
August 19, 2013
Hepeng Jia |
Chinese drug watchdog set for major reforms China's slow drug approval process has been a cause for complaint for both Chinese subsidiaries of multinational pharmaceuticals and domestic drug developers. |
The Motley Fool
July 11, 2007
Brian Lawler |
Not All Pharmaceutical Markets Are the Same The case of China's former FDA leader highlights the issues facing the country's pharmaceutical industry. Investors, take note. |
Chemistry World
March 18, 2008
Hepeng Jia |
China Announces Major Government Reshuffle In a major government reshuffle, China has created an energy watchdog and downgraded its drug regulator to improve governance in the two fields. |
Chemistry World
November 14, 2008
Hepeng Jia |
Traditional Chinese medicine firm struggles for approval HSR has spent the past eight years developing Fufang Sanhuangsan, which contains compounds derived from several plants including skullcap, dandelion and bupleurum. |
BusinessWeek
July 23, 2007
Engardio et al. |
Broken China Beijing can't clean up the environment, rein in stock speculation, or police its companies. Why the mainland's problems could keep it from becoming the next superpower |
